3 Cancer Drug Developers to Watch in the Second-half of the Year
Cancer therapies are being released in swarms, and global spending on cancer medicines reached $107…
Category: Health
Pfizer, Allergan Deal is the First Casualty of U.S. Tax Rule Changes
If you were betting on the Pfizer (PFE), Allergan (AGN) deal going through, you woke…
Pearson to Step Down as Valeant CEO, Bill Ackman Added to Board
Valeant Pharmaceuticals International Inc.’s (VRX) CEO, Mike Pearson, will step down in a shakeup of…